Singapore markets close in 5 hours 20 minutes

Rohto Pharmaceutical Co.,Ltd. (4527.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
3,239.00-41.00 (-1.25%)
As of 11:35AM JST. Market open.
Currency in JPY

Valuation measures4

Market cap (intra-day) 748.30B
Enterprise value 669.58B
Trailing P/E 24.26
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.77
Price/book (mrq)3.04
Enterprise value/revenue 2.47
Enterprise value/EBITDA 13.29

Trading information

Stock price history

Beta (5Y monthly) -0.14
52-week change 33.60%
S&P500 52-week change 325.51%
52-week high 34,117.00
52-week low 32,640.50
50-day moving average 33,015.19
200-day moving average 33,126.35

Share statistics

Avg vol (3-month) 3945.25k
Avg vol (10-day) 31.01M
Shares outstanding 5228.14M
Implied shares outstanding 6229.71M
Float 8189.11M
% held by insiders 112.03%
% held by institutions 142.10%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 430
Forward annual dividend yield 40.91%
Trailing annual dividend rate 327.00
Trailing annual dividend yield 30.82%
5-year average dividend yield 40.83
Payout ratio 419.97%
Dividend date 3N/A
Ex-dividend date 427 Sept 2024
Last split factor 22:1
Last split date 329 Dec 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 11.42%
Operating margin (ttm)7.04%

Management effectiveness

Return on assets (ttm)7.66%
Return on equity (ttm)13.59%

Income statement

Revenue (ttm)270.84B
Revenue per share (ttm)1,187.17
Quarterly revenue growth (yoy)11.70%
Gross profit (ttm)N/A
EBITDA 48.86B
Net income avi to common (ttm)30.94B
Diluted EPS (ttm)135.14
Quarterly earnings growth (yoy)0.80%

Balance sheet

Total cash (mrq)89.21B
Total cash per share (mrq)391.03
Total debt (mrq)10.49B
Total debt/equity (mrq)4.25%
Current ratio (mrq)2.47
Book value per share (mrq)1,079.71

Cash flow statement

Operating cash flow (ttm)34.24B
Levered free cash flow (ttm)15.3B